Fastly to Present at Upcoming Investor Conferences
Get Alerts FSLY Hot Sheet
Join SI Premium – FREE
SAN FRANCISCO--(BUSINESS WIRE)-- Fastly, Inc. (NYSE: FSLY), a leader in global edge cloud platforms, today announced that management will be participating in fireside chats at the following investor conferences:
-
2024 RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference in New York City on November 19th at 10:40 a.m. ET
- Presenters: Ron Kisling, Chief Financial Officer, and Vernon Essi, Jr., VP Investor Relations
-
UBS Global Technology and AI Conference in Scottsdale, AZ on December 4th at 10:15 a.m. ET
- Presenters: Todd Nightingale, Chief Executive Officer, and Ron Kisling, Chief Financial Officer
Webcasts of these presentations will be available on Fastly’s Investor Relations website at https://investors.fastly.com.
About Fastly, Inc.
Fastly’s powerful and programmable edge cloud platform helps the world’s top brands deliver online experiences that are fast, safe, and engaging through edge compute, delivery, security, and observability offerings that improve site performance, enhance security, and empower innovation at global scale. Compared to other providers, Fastly’s powerful, high-performance, and modern platform architecture empowers developers to deliver secure websites and apps with rapid time-to-market and demonstrated, industry-leading cost savings. Organizations around the world trust Fastly to help them upgrade the internet experience, including Reddit, Stripe, Neiman Marcus, Universal Music Group, and SeatGeek. Learn more about Fastly at https://www.fastly.com, and follow us @fastly.
Source: Fastly, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241105077161/en/
Investor Contact
Vernon Essi, Jr.
[email protected]
Media Contact
Spring Harris
[email protected]
Source: Fastly, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
- Best AI Tools for Small Business Marketing (2026): CapCut Featured for Creating Professional Video and Visual Content by Expert Consumers
- The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
UBS, RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share